The company also anticipates releasing its Ilizerov Type Fixator System in the next quarter, pending FDA clearance. The company’s goal is to offer value priced, high quality orthopedic implants.
More Articles on Orthopedic Implants:
BioMimetic Reports Revenue Increase in 2011 to $1.7B
17 Spine Devices Receive FDA 510(k) Clearance in February
New Test Will Fight Infection in Hip, Knee Replacements
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
